U.S. pharmaceutical care solutions provider, BioScrip, has secured a syndicated revolving credit facility worth $150 million. New York-based senior debt financing solutions provider, Healthcare Finance Group (HFG), underwrote the loan for BioScrip.

The new facility is an amendment and restatement of the previous senior secured facility which consisted of a $100 million term loan and $50 million unfunded revolver. The sole arranger, underwriter and the collateral manager for the deal is HFG.

Click here for the release from Market Wire.